Inosine pranobex is safe and effective for the treatment of subjects with confirmed acute respiratory viral infections: analysis and subgroup analysis from a Phase 4, randomised, p...

por Beran, Jiří, Šalapová, Eva, Špajdel, Marian
Publicado 2016

Inosine Pranobex Deserves Attention as a Potential Immunomodulator to Achieve Early Alteration of the COVID-19 Disease Course

por Beran, Jiří, Špajdel, Marián, Slíva, Jiří
Publicado 2021

Inosine Pranobex Significantly Decreased the Case-Fatality Rate among PCR Positive Elderly with SARS-CoV-2 at Three Nursing Homes in the Czech Republic

por Beran, Jiří, Špajdel, Marian, Katzerová, Věra, Holoušová, Alena, Malyš, Jan, Finger Rousková, Jana, Slíva, Jiří
Publicado 2020

Correction: Beran et al. Inosine Pranobex Significantly Decreased the Case-Fatality Rate among PCR Positive Elderly with SARS-CoV-2 at Three Nursing Homes in the Czech Republic. Pa...

por Beran, Jirí, Špajdel, Marian, Katzerová, Věra, Holoušová, Alena, Malyš, Jan, Rousková, Jana Finger, Slíva, Jiří
Publicado 2021

Association of Nonconcussive Repetitive Head Impacts and Intense Physical Activity With Levels of Phosphorylated Tau(181) and Total Tau in Plasma of Young Elite Soccer Players

por Cente, Martin, Perackova, Janka, Peracek, Pavol, Majdan, Marek, Toth, Igor, Mikulic, Martin, Hanes, Jozef, Porubska, Sara, Spajdel, Marian, Kazickova, Barbora, Jurisica, Igor, Filipcik, Peter
Publicado 2023